{"id":"https://openalex.org/W2001309934","doi":"https://doi.org/10.1002/mds.870050406","title":"Mitochondrial DNA analysis in Parkinson's disease","display_name":"Mitochondrial DNA analysis in Parkinson's disease","alternate_titles":[],"publication_year":1990,"publication_date":"1990-01-01","ids":{"openalex":"https://openalex.org/W2001309934","doi":"https://doi.org/10.1002/mds.870050406","mag":"2001309934","pmid":"https://pubmed.ncbi.nlm.nih.gov/1979656"},"language":"en","primary_location":{"id":"doi:10.1002/mds.870050406","doi":"https://doi.org/10.1002/mds.870050406","is_oa":false,"landing_page_url":"https://doi.org/10.1002/mds.870050406","pdf_url":null,"source":{"id":"https://openalex.org/S163027424","display_name":"Movement Disorders","issn_l":"0885-3185","issn":["0885-3185","1531-8257"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Movement Disorders","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2001309934"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059770430","display_name":"Anthony H.V. Schapira","orcid":"https://orcid.org/0000-0002-3018-3966","observed_orcids":["https://orcid.org/0000-0002-3018-3966"]},"institutions":[{"id":"https://openalex.org/I2801138448","display_name":"The Royal Free Hospital","ror":"https://ror.org/01ge67z96","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724","https://openalex.org/I2801138448"]},{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"A. H. V. Schapira","raw_affiliation_strings":["Department of Neurological Science, Royal Free Hospital School of Medicine, London, England","Department of Neurological Science, Royal Free Hospital School of Medicine, Pharmacology Group, Biomedical Science Division, King's College Hospital, London, England","University Department of Clinical Neurology, Institute of Neurology, Pharmacology Group, Biomedical Science Division, King's College Hospital, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurological Science, Royal Free Hospital School of Medicine, London, England","institution_ids":["https://openalex.org/I2801138448"]},{"raw_affiliation_string":"Department of Neurological Science, Royal Free Hospital School of Medicine, Pharmacology Group, Biomedical Science Division, King's College Hospital, London, England","institution_ids":["https://openalex.org/I2801138448","https://openalex.org/I4210153400"]},{"raw_affiliation_string":"University Department of Clinical Neurology, Institute of Neurology, Pharmacology Group, Biomedical Science Division, King's College Hospital, London, England","institution_ids":["https://openalex.org/I4210153400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013145284","display_name":"Ian James Holt","orcid":"https://orcid.org/0000-0001-5468-0193","observed_orcids":["https://orcid.org/0000-0001-5468-0193"]},"institutions":[{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I. J. Holt","raw_affiliation_strings":["University Department of Clinical Neurology, Institute of Neurology, Pharmacology Group, Biomedical Science Division, King's College Hospital, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Department of Clinical Neurology, Institute of Neurology, Pharmacology Group, Biomedical Science Division, King's College Hospital, London, England","institution_ids":["https://openalex.org/I4210153400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110213011","display_name":"Mary G. Sweeney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Sweeney","raw_affiliation_strings":["University Department of Clinical Neurology, Institute of Neurology, Pharmacology Group, Biomedical Science Division, King's College Hospital, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Department of Clinical Neurology, Institute of Neurology, Pharmacology Group, Biomedical Science Division, King's College Hospital, London, England","institution_ids":["https://openalex.org/I4210153400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071867646","display_name":"A. E. Harding","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. E. Harding","raw_affiliation_strings":["University Department of Clinical Neurology, Institute of Neurology, Pharmacology Group, Biomedical Science Division, King's College Hospital, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Department of Clinical Neurology, Institute of Neurology, Pharmacology Group, Biomedical Science Division, King's College Hospital, London, England","institution_ids":["https://openalex.org/I4210153400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105511214","display_name":"Peter G. Jenner","orcid":"https://orcid.org/0009-0006-0327-7584","observed_orcids":["https://orcid.org/0009-0006-0327-7584"]},"institutions":[{"id":"https://openalex.org/I4210103024","display_name":"Parkinson's UK","ror":"https://ror.org/02417p338","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210103024"]},{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. Jenner","raw_affiliation_strings":["Parkinson's Disease Society Experimental Research Laboratories, Pharmacology Group, Biomedical Science Division, King's College Hospital, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Parkinson's Disease Society Experimental Research Laboratories, Pharmacology Group, Biomedical Science Division, King's College Hospital, London, England","institution_ids":["https://openalex.org/I4210103024","https://openalex.org/I4210153400"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112779121","display_name":"C. DAVID MARSDEN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153400","display_name":"King's College Hospital","ror":"https://ror.org/044nptt90","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210111135","https://openalex.org/I4210153400"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. D. Marsden","raw_affiliation_strings":["University Department of Clinical Neurology, Institute of Neurology, Pharmacology Group, Biomedical Science Division, King's College Hospital, London, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Department of Clinical Neurology, Institute of Neurology, Pharmacology Group, Biomedical Science Division, King's College Hospital, London, England","institution_ids":["https://openalex.org/I4210153400"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5059770430"],"corresponding_institution_ids":["https://openalex.org/I2801138448","https://openalex.org/I4210153400"],"apc_list":{"value":4480,"currency":"USD","value_usd":4480},"apc_paid":null,"fwci":9.9526,"has_fulltext":false,"cited_by_count":114,"citation_normalized_percentile":{"value":0.98594972,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"5","issue":"4","first_page":"294","last_page":"297"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9731000065803528,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9731000065803528,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10301","display_name":"Mitochondrial Function and Pathology","score":0.015300000086426735,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13012","display_name":"Coenzyme Q10 studies and effects","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9959999918937683},{"id":"https://openalex.org/keywords/mitochondrial-dna","display_name":"mitochondrial DNA","score":0.9819999933242798},{"id":"https://openalex.org/keywords/complex-i","display_name":"complex I","score":0.8859999775886536},{"id":"https://openalex.org/keywords/substantia-nigra","display_name":"substantia nigra","score":0.8640000224113464},{"id":"https://openalex.org/keywords/mptp","display_name":"MPTP","score":0.859000027179718},{"id":"https://openalex.org/keywords/parkinsonism","display_name":"parkinsonism","score":0.6510000228881836},{"id":"https://openalex.org/keywords/mitochondrial-dna-polymorphism","display_name":"mitochondrial DNA polymorphism","score":0.6679999828338623},{"id":"https://openalex.org/keywords/restriction-fragment-length-polymorphism","display_name":"restriction fragment length polymorphism","score":0.7549999952316284},{"id":"https://openalex.org/keywords/mitochondrial-dna-deletions","display_name":"mitochondrial DNA deletions","score":0.5619999766349792}],"concepts":[{"id":"https://openalex.org/C2780938664","wikidata":"https://www.wikidata.org/wiki/Q753278","display_name":"Substantia nigra","level":4,"score":0.9298117160797119},{"id":"https://openalex.org/C2778674702","wikidata":"https://www.wikidata.org/wiki/Q239816","display_name":"MPTP","level":4,"score":0.8604402542114258},{"id":"https://openalex.org/C2776525014","wikidata":"https://www.wikidata.org/wiki/Q1531991","display_name":"Parkinsonism","level":3,"score":0.8017309308052063},{"id":"https://openalex.org/C2780358027","wikidata":"https://www.wikidata.org/wiki/Q407752","display_name":"Neurotoxin","level":2,"score":0.7128533720970154},{"id":"https://openalex.org/C24586158","wikidata":"https://www.wikidata.org/wiki/Q27075","display_name":"Mitochondrial DNA","level":3,"score":0.6431798338890076},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.6184793710708618},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4886985123157501},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.44123539328575134},{"id":"https://openalex.org/C2776901170","wikidata":"https://www.wikidata.org/wiki/Q12499775","display_name":"Nicotinamide adenine dinucleotide","level":4,"score":0.43231990933418274},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.420652836561203},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3789745271205902},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3356606364250183},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2931661009788513},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.29079872369766235},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28885191679000854},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.26375141739845276},{"id":"https://openalex.org/C75520062","wikidata":"https://www.wikidata.org/wiki/Q15321392","display_name":"NAD+ kinase","level":3,"score":0.19958895444869995},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11673980951309204}],"mesh":[{"descriptor_ui":"D004249","descriptor_name":"DNA Damage","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D004272","descriptor_name":"DNA, Mitochondrial","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D011808","descriptor_name":"Quinone Reductases","qualifier_ui":"Q000172","qualifier_name":"deficiency","is_major_topic":false},{"descriptor_ui":"D012150","descriptor_name":"Polymorphism, Restriction Fragment Length","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D016660","descriptor_name":"NAD(P)H Dehydrogenase (Quinone)","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/mds.870050406","doi":"https://doi.org/10.1002/mds.870050406","is_oa":false,"landing_page_url":"https://doi.org/10.1002/mds.870050406","pdf_url":null,"source":{"id":"https://openalex.org/S163027424","display_name":"Movement Disorders","issn_l":"0885-3185","issn":["0885-3185","1531-8257"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Movement Disorders","raw_type":"journal-article"},{"id":"pmid:1979656","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1979656","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Movement disorders : official journal of the Movement Disorder Society","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:127546","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/127546/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"MOVEMENT DISORD , 5 (4) 294 - 297. (1990)","raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1602098835","https://openalex.org/W1969800514","https://openalex.org/W1971062646","https://openalex.org/W1996001974","https://openalex.org/W1996774271","https://openalex.org/W2002302457","https://openalex.org/W2005873512","https://openalex.org/W2014669590","https://openalex.org/W2038557175","https://openalex.org/W2039403847","https://openalex.org/W2041867957","https://openalex.org/W2042769356","https://openalex.org/W2055308573","https://openalex.org/W2059649326","https://openalex.org/W2059718548","https://openalex.org/W2062251719","https://openalex.org/W2063450941","https://openalex.org/W2077260129","https://openalex.org/W2077414996","https://openalex.org/W2089518139","https://openalex.org/W2091390708","https://openalex.org/W2095397705","https://openalex.org/W2103154453","https://openalex.org/W2109291482","https://openalex.org/W2109656063","https://openalex.org/W2115688047","https://openalex.org/W2146889361","https://openalex.org/W2403119120","https://openalex.org/W2993552196","https://openalex.org/W4239095340"],"related_works":["https://openalex.org/W2055308573","https://openalex.org/W1991511436","https://openalex.org/W3043387758","https://openalex.org/W2260823531","https://openalex.org/W2022164794","https://openalex.org/W2038703875","https://openalex.org/W1967045147","https://openalex.org/W2024046487"],"abstract_inverted_index":{"The":[0],"reduced":[1],"form":[2],"of":[3,24,55,65],"nicotinamide":[4],"adenine":[5],"dinucleotide":[6],"coenzyme":[7],"Q":[8],"reductase":[9],"(complex":[10],"I)":[11],"activity":[12],"has":[13],"recently":[14],"been":[15],"shown":[16],"to":[17,35],"be":[18],"deficient":[19],"in":[20,47,93],"the":[21,39],"substantia":[22,66],"nigra":[23,67],"patients":[25,71],"dying":[26],"with":[27,72],"Parkinson's":[28,73],"disease.":[29],"This":[30],"biochemical":[31],"defect":[32],"is":[33],"identical":[34],"that":[36,89],"produced":[37],"by":[38,59],"neurotoxin":[40],"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine":[41],"(MPTP),":[42],"which":[43,56],"also":[44],"produces":[45],"parkinsonism":[46],"humans.":[48],"Complex":[49],"I":[50],"comprises":[51],"25":[52],"polypeptides,":[53],"seven":[54],"are":[57],"encoded":[58],"mitochondrial":[60],"DNA.":[61],"Restriction":[62],"fragment":[63],"analysis":[64],"DNA":[68],"from":[69],"six":[70],"disease":[74],"did":[75],"not":[76,91],"show":[77],"any":[78],"major":[79],"deletion.":[80],"In":[81],"two":[82],"cases,":[83],"there":[84],"were":[85,90],"different":[86],"novel":[87],"polymorphisms":[88],"observed":[92],"control":[94],"brain":[95],"(n":[96,101],"=":[97,102],"6)":[98],"or":[99],"blood":[100],"34)":[103],"samples.":[104]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2001309934","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
